Class information for:
Level 1: BONE TYPE I COLLAGEN//LEPROSY PATIENTS UNTREATED//PIDOTIMOD IMMUNOSTIMULATION PHARMACOLOGY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
33675 121 28.2 32%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
116 3       MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS 70215
469 2             MUTATION RESEARCH//MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS//COMET ASSAY 15922
33675 1                   BONE TYPE I COLLAGEN//LEPROSY PATIENTS UNTREATED//PIDOTIMOD IMMUNOSTIMULATION PHARMACOLOGY 121

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BONE TYPE I COLLAGEN authKW 252360 1% 100% 1
2 LEPROSY PATIENTS UNTREATED authKW 252360 1% 100% 1
3 PIDOTIMOD IMMUNOSTIMULATION PHARMACOLOGY authKW 252360 1% 100% 1
4 SERV VIXILANCIA SAUDE address 252360 1% 100% 1
5 SI PHARMACOL TOXICOL address 252358 2% 50% 2
6 TUBERCULOSIS CHEMOTHERAPY authKW 201886 2% 40% 2
7 ROVAMYCIN authKW 126179 1% 50% 1
8 CENT HOSP ANAESTHESIOL address 84119 1% 33% 1
9 WP2 MUTAGENICITY TEST authKW 84119 1% 33% 1
10 POLYADP RIBOSE POLYMERASE INHIBITION authKW 50470 1% 20% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Toxicology 556 21% 0% 25
2 Tropical Medicine 432 9% 0% 11
3 Genetics & Heredity 378 24% 0% 29
4 Immunology 165 19% 0% 23
5 Dermatology 79 7% 0% 8
6 Pharmacology & Pharmacy 49 14% 0% 17
7 Oncology 42 12% 0% 14
8 Pathology 40 6% 0% 7
9 CYTOLOGY & HISTOLOGY 32 1% 0% 1
10 Medical Laboratory Technology 22 2% 0% 3

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SERV VIXILANCIA SAUDE 252360 1% 100% 1
2 SI PHARMACOL TOXICOL 252358 2% 50% 2
3 CENT HOSP ANAESTHESIOL 84119 1% 33% 1
4 BOTUCATU MED UNESP 25234 1% 10% 1
5 CENT HOSP SURG 22940 1% 9% 1
6 INVEST ANAL ALIMENTARIAS 15771 1% 6% 1
7 THORAC SURG LUNG TRANSPLANTAT UNIT 8410 1% 3% 1
8 CA GRANDA OSPED MAGGIORE POLICLIN 4004 1% 2% 1
9 EXAMINAT 4004 1% 2% 1
10 QUAL OPERAT 3275 1% 1% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 8616 5% 1% 6
2 MUTATION RESEARCH 5257 11% 0% 13
3 LEPROSY REVIEW 4519 4% 0% 5
4 CRC CRITICAL REVIEWS IN MICROBIOLOGY 2497 1% 1% 1
5 TUBERCLE 2229 2% 0% 2
6 HUMAN TOXICOLOGY 2060 2% 0% 2
7 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 1988 3% 0% 4
8 MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS 1491 1% 1% 1
9 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 1310 2% 0% 2
10 MUTAGENESIS 1002 2% 0% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BONE TYPE I COLLAGEN 252360 1% 100% 1 Search BONE+TYPE+I+COLLAGEN Search BONE+TYPE+I+COLLAGEN
2 LEPROSY PATIENTS UNTREATED 252360 1% 100% 1 Search LEPROSY+PATIENTS+UNTREATED Search LEPROSY+PATIENTS+UNTREATED
3 PIDOTIMOD IMMUNOSTIMULATION PHARMACOLOGY 252360 1% 100% 1 Search PIDOTIMOD+IMMUNOSTIMULATION+PHARMACOLOGY Search PIDOTIMOD+IMMUNOSTIMULATION+PHARMACOLOGY
4 TUBERCULOSIS CHEMOTHERAPY 201886 2% 40% 2 Search TUBERCULOSIS+CHEMOTHERAPY Search TUBERCULOSIS+CHEMOTHERAPY
5 ROVAMYCIN 126179 1% 50% 1 Search ROVAMYCIN Search ROVAMYCIN
6 WP2 MUTAGENICITY TEST 84119 1% 33% 1 Search WP2+MUTAGENICITY+TEST Search WP2+MUTAGENICITY+TEST
7 POLYADP RIBOSE POLYMERASE INHIBITION 50470 1% 20% 1 Search POLYADP+RIBOSE+POLYMERASE+INHIBITION Search POLYADP+RIBOSE+POLYMERASE+INHIBITION
8 CEPHALOSPORIN ANTIBIOTIC 28038 1% 11% 1 Search CEPHALOSPORIN+ANTIBIOTIC Search CEPHALOSPORIN+ANTIBIOTIC
9 CYTOGENETIC EFFECTS 25879 2% 5% 2 Search CYTOGENETIC+EFFECTS Search CYTOGENETIC+EFFECTS
10 RAT LIVER S9 25234 1% 10% 1 Search RAT+LIVER+S9 Search RAT+LIVER+S9

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 GANDHI, G , SINGH, B , (2004) DNA DAMAGE STUDIES IN UNTREATED AND TREATED LEPROSY PATIENTS.MUTAGENESIS. VOL. 19. ISSUE 6. P. 483-488 11 37% 5
2 KALAISELVI, K , RAJAGURU, P , PALANIVEL, M , USHARANI, MV , RAMU, G , (2002) CHROMOSOMAL ABERRATION, MICRONUCLEUS AND COMET ASSAYS ON PERIPHERAL BLOOD LYMPHOCYTES OF LEPROSY PATIENTS UNDERGOING MULTIDRUG TREATMENT.MUTAGENESIS. VOL. 17. ISSUE 4. P. 309-312 7 58% 14
3 EKMEKCI, A , SAYLI, A , (1995) CYTOGENETIC STUDY OF TUBERCULOSIS PATIENTS BEFORE AND AFTER TUBERCULOSTATIC DRUG-TREATMENT.MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS. VOL. 334. ISSUE 2. P. 175-183 6 86% 1
4 BAJPAI, J , SHETTY, N , GUPTA, A , SAMAR, A , KELKAR, R , (2013) A CASE REPORT OF OSTEOGENIC SARCOMA WITH LEPROSY.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 9. ISSUE 2. P. 311-313 3 75% 0
5 DSOUZA, D , DAS, BC , THOMAS, IM , (1991) CYTOGENETIC STUDIES IN LEPROSY PATIENTS BEFORE AND AFTER CHEMOTHERAPY.HUMAN GENETICS. VOL. 87. ISSUE 6. P. 665-670 7 64% 4
6 DSOUZA, D , DAS, BC , (1994) GENOTOXIC EFFECTS OF MYCOBACTERIUM-LEPRAE INFECTION IN HUMANS.MUTATION RESEARCH. VOL. 305. ISSUE 2. P. 211-222 13 30% 7
7 MAHAJAN, N , RAO, S , SOBTI, P , KHURANA, N , GARG, VK , JAIN, S , (2012) ANAPLASTIC LARGE CELL LYMPHOMA AND LEPROMATOUS LEPROSY: A RARE COEXISTENCE.LEPROSY REVIEW. VOL. 83. ISSUE 1. P. 104-107 2 100% 1
8 FATIMA, R , ASHRAF, M , EJAZ, S , RASHEED, MA , ALTAF, I , AFZAL, M , BATOOL, Z , SALEEM, U , ANWAR, K , (2013) IN VITRO TOXIC ACTION POTENTIAL OF ANTI TUBERCULOSIS DRUGS AND THEIR COMBINATIONS.ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. VOL. 36. ISSUE 2. P. 501-513 7 25% 4
9 BECK, JS , POTTS, RC , BROWN, RA , DERAEDT, R , (1987) SUPPRESSION OF GROWTH OF PHA-STIMULATED HUMAN-LYMPHOCYTES BY A NOVEL STEROID (RU-28-362) LACKING THE 21-OH GROUP.INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 9. ISSUE 8. P. 861-867 6 75% 1
10 BAGLA, N , PATEL, MM , PATEL, RD , JARAG, M , (2005) LEPROMATOUS LYMPHADENITIS MASQUERADING AS LYMPHOMA.LEPROSY REVIEW. VOL. 76. ISSUE 1. P. 87-90 2 100% 3

Classes with closest relation at Level 1


Rank Class id link
1 6859 SISTER CHROMATID EXCHANGE//MUTATION RESEARCH//SISTER CHROMATID EXCHANGE FREQUENCY
2 31475 PREMATURE CENTROMERE DIVISION//VARIEGATED ANEUPLOIDY//C ANAPHASES
3 32747 TB CANC CELL BIOL//BIOCHEM CLAYTON FDN//BSA FRACTION V
4 21666 NON MITOCHONDRIAL PATHWAY//5HT3 AND 5HT4 RECEPTORS//AGONIST AND ANTAGONISTS
5 36346 METAPHENOXY BENZYL CHLORIDE//MUTATION RESEARCH//GENOTOXICITY ASSAY
6 37248 INVEST BIOMED ARTADO POSTAL 70228//ANTHELMINTIC EXPOSURE//APPLICATION FOR MARKETING AUTHORIZATION
7 32534 SKIN ISCHEMIA//SO BUR//ASCITES CELLS
8 22914 CATTADRA CLIN MED 2A//CATTEDRA PATOL MED 1A//PILOT UNIT
9 30153 2 AMINO 2 OXAZOLINE//CHIM THER EUT BIOCIS//2 AMINO 2 IMIDAZOLINE
10 18656 CLOFAZIMINE//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//B669

Go to start page